Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corp    CVS

Delayed Quote. Delayed  - 01/20 10:00:53 pm
81.56 USD   -1.38%
01/20 FTC NOT SOLD ON : Bloomberg
01/20 CVS HEALTH CORP : ex-dividend day
01/19DJRival to EpiPen Allergy Treatment to Return to Market--Update
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Court Rules Two CVS Florida Pharmacies Can't Ship Pain Pills

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/22/2012 | 11:59pm CET
   By John Kell 
   Of  
 

A U.S. appeals court said two CVS Caremark Corp. (>> CVS Caremark Corporation) pharmacies in Florida cannot fill prescriptions for certain controlled drugs related to a Drug Enforcement Administration move to halt such sales.

The decision lifted a temporary, administrative stay that was granted to CVS earlier this month, at the time allowing the pharmacies to keep dispensing controlled medications after an appeals court denied the chain's request for preliminary injunction.

The case stems from DEA action that was taken last month against two Sanford, Fla., CVS stores that were alleged to be among four pharmacy customers of drug distributor Cardinal Health Inc. (CAH) that dispensed the pain drug oxycodone based on bad prescriptions.

The U.S. Court of Appeals for the District of Columbia Circuit on Thursday ruled CVS had "not satisfied the stringent requirements for a stay pending appeal." The decision comes roughly a week after an appeals court said a Cardinal Health distribution hub in Florida can't ship prescription painkillers.

In a prepared statement, CVS said it was "disappointed with today's ruling by the court," saying the company had taken actions that have substantially reduced the amount of oxycodone dispensed at the two Florida pharmacies.

"We remain committed to working with the DEA to do everything we can to reduce prescription drug abuse," CVS said.

-By John Kell, Dow Jones Newswires; 212-416-2480; john.kell@dowjones.com

-Jon Kamp and Timothy Martin of The Wall Street Journal contributed to this article

Stocks mentioned in the article : CVS Caremark Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORP
01/20 FTC NOT SOLD ON WALGREENS' PLAN TO W : Bloomberg
01/20 CVS HEALTH CORP : ex-dividend day
01/19DJRival to EpiPen Allergy Treatment to Return to Market--Update
01/19DJRival to EpiPen Allergy Treatment to Return to Market
01/19 CVS HEALTH : Offers Patients Lowest Cash Price in the Market for Generic Epineph..
01/14 CVS HEALTH : Canada Pension Plan Investment Board Has $249,866,000 Position in C..
01/14 CVS HEALTH : targets EpiPen with cheaper, generic version
01/13 CVS HEALTH : unveils generic competitor to EpiPen for one-sixth the price
01/13 CVS HEALTH : More Mylan misery
01/13 CVS HEALTH : Vende CVS versión genérica de Epipen a un sexto de su precio
More news
Sector news : Drug Retailers - NEC
01/20 FTC NOT SOLD ON WALGREENS' PLAN TO W : Bloomberg
01/18DJMCKESSON : to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders --..
01/18DJMCKESSON : to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders
01/11DJWalgreens to Offer FedEx Dropoff and Pickup at Walgreens Locations Nationwide
01/05 U.S. loses bid to overturn AmEx antitrust decision
More sector news : Drug Retailers - NEC
News from SeekingAlpha
01/20 Implications Of The Latest Smash In Bristol-Myers Squibb Stock
01/20 Buy PepsiCo At $99 - Cramer's Lightning Round (1/19/17)
01/20 CVS Health goes ex-dividend today
01/19 ONE STEP CLOSER TO FINANCIAL FREEDOM : My 2016 Income Review
01/17 DGI FOR THE DIY : 2016 Portfolio Review
Advertisement
Financials ($)
Sales 2016 178 062 M
EBIT 2016 10 773 M
Net income 2016 5 672 M
Debt 2016 24 653 M
Yield 2016 1,97%
P/E ratio 2016 16,33
P/E ratio 2017 15,53
EV / Sales 2016 0,64x
EV / Sales 2017 0,61x
Capitalization 88 728 M
More Financials
Chart CVS HEALTH CORP
Duration : Period :
CVS Health Corp Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Full-screen chart
Technical analysis trends CVS HEALTH CORP
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 88,0 $
Spread / Average Target 5,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Stephen J. Gold Chief Information Officer & Executive Vice Preside
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORP5.44%88 728
WALGREENS BOOTS ALLIAN..0.88%90 120
EXPRESS SCRIPTS HOLDIN..5.32%44 674
MCKESSON CORPORATION4.87%33 300
CARDINAL HEALTH INC4.97%24 181
AMERISOURCEBERGEN CORP..9.31%18 812
More Results